Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 6/2017

01-06-2017 | Clinical Investigation

A Single-Institution Experience in Percutaneous Image-Guided Biopsy of Malignant Pleural Mesothelioma

Authors: B. T. Welch, P. W. Eiken, T. D. Atwell, T. Peikert, E. S. Yi, F. Nichols, G. D. Schmit

Published in: CardioVascular and Interventional Radiology | Issue 6/2017

Login to get access

Abstract

Purpose

Mesothelioma has been considered a difficult pathologic diagnosis to achieve via image-guided core needle biopsy. The purpose of this study was to assess the diagnostic sensitivity of percutaneous image-guided biopsy for diagnosis of pleural mesothelioma.

Materials and Methods

Retrospective review was performed to identify patients with a confirmed diagnosis of pleural mesothelioma and who underwent image-guided needle biopsy between January 1, 2002, and January 1, 2016. Thirty-two patients with pleural mesothelioma were identified and included for analysis in 33 image-guided biopsy procedures. Patient, procedural, and pathologic characteristics were recorded. Complications were characterized via standardized nomenclature [Common Terminology for Clinically Adverse Events (CTCAE)].

Results

Percutaneous image-guided biopsy was associated with an overall sensitivity of 81%. No CTCAE clinically significant complications were observed. No image-guided procedures were complicated by pneumothorax or necessitated chest tube placement. No patients had tumor seeding of the biopsy tract.

Conclusion

Percutaneous image-guided biopsy can achieve high sensitivity for pathologic diagnosis of pleural mesothelioma with a low procedural complication rate, potentially obviating need for surgical biopsy.
Literature
1.
go back to reference Armato SG 3rd, et al. Imaging in pleural mesothelioma: a review of the 11th international conference of the international mesothelioma interest group. Lung Cancer. 2013;82(2):190–6.CrossRefPubMed Armato SG 3rd, et al. Imaging in pleural mesothelioma: a review of the 11th international conference of the international mesothelioma interest group. Lung Cancer. 2013;82(2):190–6.CrossRefPubMed
2.
go back to reference Miller BH, et al. From the archives of the AFIP. Malignant pleural mesothelioma: radiologic–pathologic correlation. Radiographics. 1996;16(3):613–44.CrossRefPubMed Miller BH, et al. From the archives of the AFIP. Malignant pleural mesothelioma: radiologic–pathologic correlation. Radiographics. 1996;16(3):613–44.CrossRefPubMed
3.
go back to reference Porpodis K, et al. Malignant pleural mesothelioma: current and future perspectives. J Thorac Dis. 2013;5(Suppl 4):S397–406.PubMedPubMedCentral Porpodis K, et al. Malignant pleural mesothelioma: current and future perspectives. J Thorac Dis. 2013;5(Suppl 4):S397–406.PubMedPubMedCentral
4.
go back to reference Seely JM, et al. Malignant pleural mesothelioma: computed tomography and correlation with histology. Eur J Radiol. 2009;70(3):485–91.CrossRefPubMed Seely JM, et al. Malignant pleural mesothelioma: computed tomography and correlation with histology. Eur J Radiol. 2009;70(3):485–91.CrossRefPubMed
5.
go back to reference Agarwal PP, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy. Radiol. 2006;241(2):589–94.CrossRef Agarwal PP, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy. Radiol. 2006;241(2):589–94.CrossRef
6.
go back to reference Boutin C, Astoul P, Seitz B. The role of thoracoscopy in the evaluation and management of pleural effusions. Lung. 1990;168(Suppl):1113–21.CrossRefPubMed Boutin C, Astoul P, Seitz B. The role of thoracoscopy in the evaluation and management of pleural effusions. Lung. 1990;168(Suppl):1113–21.CrossRefPubMed
7.
go back to reference Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med. 1991;114(4):271–6.CrossRefPubMed Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med. 1991;114(4):271–6.CrossRefPubMed
8.
go back to reference Zahid I, et al. What is the best way to diagnose and stage malignant pleural mesothelioma? Interact CardioVasc Thorac Surg. 2011;12(2):254–9.CrossRefPubMed Zahid I, et al. What is the best way to diagnose and stage malignant pleural mesothelioma? Interact CardioVasc Thorac Surg. 2011;12(2):254–9.CrossRefPubMed
9.
go back to reference Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995;108(3):754–8.CrossRefPubMed Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995;108(3):754–8.CrossRefPubMed
10.
go back to reference Adams RF, et al. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest. 2001;120(6):1798–802.CrossRefPubMed Adams RF, et al. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest. 2001;120(6):1798–802.CrossRefPubMed
11.
go back to reference Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet. 2003;361(9366):1326–30.CrossRefPubMed Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet. 2003;361(9366):1326–30.CrossRefPubMed
12.
go back to reference Metintas M, et al. CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma. J Comput Assist Tomogr. 1995;19(3):370–4.CrossRefPubMed Metintas M, et al. CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma. J Comput Assist Tomogr. 1995;19(3):370–4.CrossRefPubMed
13.
go back to reference Scott EM, et al. Diffuse pleural thickening: percutaneous CT-guided cutting needle biopsy. Radiology. 1995;194(3):867–70.CrossRefPubMed Scott EM, et al. Diffuse pleural thickening: percutaneous CT-guided cutting needle biopsy. Radiology. 1995;194(3):867–70.CrossRefPubMed
14.
go back to reference Atwell TD, et al. Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR Am J Roentgenol. 2010;194(3):784–9.CrossRefPubMed Atwell TD, et al. Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR Am J Roentgenol. 2010;194(3):784–9.CrossRefPubMed
15.
go back to reference Atwell TD, et al. The timing and presentation of major hemorrhage after 18,947 image-guided percutaneous biopsies. AJR Am J Roentgenol. 2015;205(1):190–5.CrossRefPubMed Atwell TD, et al. The timing and presentation of major hemorrhage after 18,947 image-guided percutaneous biopsies. AJR Am J Roentgenol. 2015;205(1):190–5.CrossRefPubMed
16.
go back to reference Olson MC, et al. Safety and accuracy of percutaneous image-guided core biopsy of the spleen. AJR Am J Roentgenol. 2016;206(3):655–9.CrossRefPubMed Olson MC, et al. Safety and accuracy of percutaneous image-guided core biopsy of the spleen. AJR Am J Roentgenol. 2016;206(3):655–9.CrossRefPubMed
17.
go back to reference National Cancer Institute. Common terminology criteria for adverse events (CTCAE) version 4.0; 2009. National Cancer Institute. Common terminology criteria for adverse events (CTCAE) version 4.0; 2009.
18.
go back to reference Attanoos RL, Gibbs AR. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology. 2008;53(3):340–4.CrossRefPubMed Attanoos RL, Gibbs AR. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology. 2008;53(3):340–4.CrossRefPubMed
19.
go back to reference Heilo A, Stenwig AE, Solheim OP. Malignant pleural mesothelioma: US-guided histologic core-needle biopsy. Radiology. 1999;211(3):657–9.CrossRefPubMed Heilo A, Stenwig AE, Solheim OP. Malignant pleural mesothelioma: US-guided histologic core-needle biopsy. Radiology. 1999;211(3):657–9.CrossRefPubMed
20.
go back to reference Metintas M, et al. Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial. Chest. 2010;137(6):1362–8.CrossRefPubMed Metintas M, et al. Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial. Chest. 2010;137(6):1362–8.CrossRefPubMed
21.
go back to reference Metintas M, et al. CT scan-guided Abrams’ needle pleural biopsy versus ultrasound-assisted cutting needle pleural biopsy for diagnosis in patients with pleural effusion: a randomized controlled trial. Respiration. 2016;91(2):156–63.CrossRefPubMed Metintas M, et al. CT scan-guided Abrams’ needle pleural biopsy versus ultrasound-assisted cutting needle pleural biopsy for diagnosis in patients with pleural effusion: a randomized controlled trial. Respiration. 2016;91(2):156–63.CrossRefPubMed
22.
go back to reference Bydder S, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer. 2004;91(1):9–10.CrossRefPubMedPubMedCentral Bydder S, et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer. 2004;91(1):9–10.CrossRefPubMedPubMedCentral
23.
go back to reference Clive AO, et al. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial. Lancet Oncol. 2016;17(8):1094–104.CrossRefPubMedPubMedCentral Clive AO, et al. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial. Lancet Oncol. 2016;17(8):1094–104.CrossRefPubMedPubMedCentral
24.
go back to reference Davies HE, Musk AW, Lee YC. Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues. Curr Opin Pulm Med. 2008;14(4):326–30.CrossRefPubMed Davies HE, Musk AW, Lee YC. Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues. Curr Opin Pulm Med. 2008;14(4):326–30.CrossRefPubMed
25.
go back to reference De Ruysscher D, Slotman B. Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2003;68(3):299–302.CrossRef De Ruysscher D, Slotman B. Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2003;68(3):299–302.CrossRef
26.
go back to reference Nagendran M, et al. Should all patients who have mesothelioma diagnosed by video-assisted thoracoscopic surgery have their intervention sites irradiated? Interact CardioVasc Thorac Surg. 2011;13(1):66–9.CrossRefPubMed Nagendran M, et al. Should all patients who have mesothelioma diagnosed by video-assisted thoracoscopic surgery have their intervention sites irradiated? Interact CardioVasc Thorac Surg. 2011;13(1):66–9.CrossRefPubMed
27.
go back to reference O’Rourke N, et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2007;84(1):18–22.CrossRef O’Rourke N, et al. A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2007;84(1):18–22.CrossRef
28.
go back to reference West SD, Foord T, Davies RJ. Needle-track metastases and prophylactic radiotherapy for mesothelioma. Respir Med. 2006;100(6):1037–40.CrossRefPubMed West SD, Foord T, Davies RJ. Needle-track metastases and prophylactic radiotherapy for mesothelioma. Respir Med. 2006;100(6):1037–40.CrossRefPubMed
Metadata
Title
A Single-Institution Experience in Percutaneous Image-Guided Biopsy of Malignant Pleural Mesothelioma
Authors
B. T. Welch
P. W. Eiken
T. D. Atwell
T. Peikert
E. S. Yi
F. Nichols
G. D. Schmit
Publication date
01-06-2017
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 6/2017
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-017-1583-7

Other articles of this Issue 6/2017

CardioVascular and Interventional Radiology 6/2017 Go to the issue